David McClung insider trades
Open-market stock purchases and sales by David McClung, Chief Financial Officer at BioCardia, Inc, from SEC Form 4 filings since Feb 1, 2018.
Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -57%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 6, 2026 | BCDA BioCardia, Inc | Bought (not open market) | — |
| Jul 2, 2026 | BCDA BioCardia, Inc | Sold (not open market) | $28.7K |
| Jun 29, 2026 | BCDA BioCardia, Inc | Bought (not open market) | $72.6K |
| Dec 8, 2025 | BCDA BioCardia, Inc | Bought (not open market) | $79.8K |
| Dec 8, 2025 | BCDA BioCardia, Inc | Bought (not open market) | $40.2K |
| Dec 8, 2025 | BCDA BioCardia, Inc | Bought (not open market) | — |
Companies traded
- BCDA BioCardia, Inc: 7 buys, last Jul 6, 2026
- BCDA;BCDAW BioCardia, Inc: 2 buys, last Jun 23, 2023